The effector phase of an antigen specific immune response, involving multiple interactions between cells, is described as being either humoral or cell mediated. The pathological consequences of an immune response are mainly determined by the effector pathway chosen. Although the effector mechanisms are well characterized, the mechanism by which a response to a given antigen or infectious agent is directed into the humoral or cell mediated mode is not known. The major focus of this proposal is to study the mechanism by which the immune system directs a particular responses into one of these 2 pathways. Both types of effector responses depend upon the activation of CD4+ T cells. CD4+ T cells are helper cells for B cells, mediators of delayed type hypersensitivity responses, and helper cells for cytolytic T cell responses. Analysis of cloned T cells have shown that not all cloned lines mediate all these functions. Cloned CD4+ T cells can be divided into 2 subsets which are functionally distinct. One subset induces antigen specific B cells to secrete and the other subset mediates delayed type hypersensitivity responses, suppresses antibody production and kills appropriate target cells. These two subsets appear to induce effector responses which are primarily humoral or cell mediated. In this proposal, the activation requirements of the 2 functionally distinct subset will be studied in an attempt to understand the control of humoral and cell mediated responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026791-02
Application #
3140753
Study Section
Immunobiology Study Section (IMB)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Knapp, Bernhard; Omasits, Ulrich; Schreiner, Wolfgang et al. (2010) A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses. PLoS One 5:e11653
Jackman, Rachael P; Balamuth, Fran; Bottomly, Kim (2007) CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets. J Immunol 178:5543-51
Jorritsma, Patricia J; Brogdon, Jennifer L; Bottomly, Kim (2003) Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J Immunol 170:2427-34
Eisenbarth, Stephanie C; Piggott, Damani A; Huleatt, James W et al. (2002) Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196:1645-51
Brogdon, Jennifer L; Leitenberg, David; Bottomly, Kim (2002) The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells. J Immunol 168:3825-32
Constant, Stephanie L; Brogdon, Jennifer L; Piggott, Damani A et al. (2002) Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 110:1441-8
He, Xin; Janeway Jr, Charles A; Levine, Matthew et al. (2002) Dual receptor T cells extend the immune repertoire for foreign antigens. Nat Immunol 3:127-34
Constant, S L; Lee, K S; Bottomly, K (2000) Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 30:840-7
Welte, T; Leitenberg, D; Dittel, B N et al. (1999) The PTK-STAT signaling pathway has essential roles in T-cell activation in response to antigen stimulation. Cold Spring Harb Symp Quant Biol 64:291-302
Leitenberg, D; Bottomly, K (1999) Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 11:283-92

Showing the most recent 10 out of 25 publications